The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better than average stocks (as part of a diversified portfolio). For example, the ...
Enhance Skin Products Inc. Announces a Strategic Collaboration With Integumen Limited and Asset Sale
RENO, NV--(Marketwired - Oct 4, 2016) - Enhance Skin Products Inc., (OTC PINK: EHSK) is pleased to make the following announcement: Enhance Skin Products Inc., a pioneer in hyaluronan ("HA") research ...
(Alliance News) - Integumen PLC on Friday announced it had agreed terms for the acquisition of Modern Water PLC in an all-share deal that values the London-based wastewater firm at around GBP21.3 ...
LONDON, Sept 24 (Reuters) - Integumen (SKINI.L), opens new tab, a British company that developed a system to detect the COVID-19 virus in waste water, said the same technology could be deployed in a ...
Dublin-headquartered health technology company Integumen has agreed to acquire an Essex business which has developed a system to make biodegradable plastic components that can be used in the packaging ...
(Sharecast News) - Life sciences outfit Integumen agreed to acquire data management firm RinoCloud for a total of £3m on Friday as part of its efforts to build out its Labskin AI platform.Integumen, ...
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, has entered into a collaboration with Integumen plc (Integumen) to evaluate recently generated Affimer reagents that bind the ...
Dalkey-based Integumen is to raise £1.4 million (€1.66 million) through a share placing and subscription to provide working capital as it looks to boost revenues from a projected £1 million (€1.1 ...
Drug development firm Venn Life Sciences said it reported an overall loss of €1.5 million for last year as charges related to its investment in Dalkey-based Integumen hit its balance sheet. The ...
Integumen , a British company that developed a system to detect the COVID-19 virus in waste water, said the same technology could be deployed in a personalised breath test that could become an ...
Dalkey-based healthcare company Integumen is planning to raise £2.25m (€2.6m) via a listing on the Alternative Investment Market in London. The company, chaired by Venn Life Sciences' chief executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback